Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03105921
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:43.939574+00:00
Published At
2022-03-31T00:00:00+00:00
Record Updated At
2022-03-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Adenocarcinoma", "Interventional Imaging"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-31"
protocolSection.identificationModule.nctId
"NCT03105921"
protocolSection.identificationModule.officialTitle
"Int\u00e9r\u00eat de l\u0027\u00e9lectroporation irr\u00e9versible Dans le Traitement de l\u0027ad\u00e9nocarcinome du pancr\u00e9as"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Interventional Imaging (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.